PASG Passage Bio, Inc.
Passage Bio, Inc. (PASG) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $75.2K.
Where they traded
Last open-market purchase: June 25, 2026 .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Buy | 50,055 | $4.12 | $206.1K | 673,759 | |||
| Chou William | PRESIDENT AND CEO | Sell | 4,076 | $18.44 | $75.2K | 6,524 −38.5% of holding | |
| Borthwick Kathleen | CFO | Sell | 2,062 | $18.44 | $38.0K | 5,402 −27.6% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.